These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2137786)

  • 1. Prognostic significance of immune function parameters in patients with chronic lymphocytic leukaemia.
    Apostolopoulos A; Symeonidis A; Zoumbos N
    Eur J Haematol; 1990 Jan; 44(1):39-44. PubMed ID: 2137786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological variants of leukemic cells in B chronic lymphocytic leukemia are associated with different T cell and NK cell abnormalities.
    Reyes E; Prieto A; Carrion F; Garcia-Suarez J; Esquivel F; Alvarez-Mon M
    Am J Hematol; 1997 Aug; 55(4):175-82. PubMed ID: 9257876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia.
    Palmer S; Hanson CA; Zent CS; Porrata LF; Laplant B; Geyer SM; Markovic SN; Call TG; Bowen DA; Jelinek DF; Kay NE; Shanafelt TD
    Br J Haematol; 2008 May; 141(5):607-14. PubMed ID: 18384436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease.
    Tötterman TH; Carlsson M; Simonsson B; Bengtsson M; Nilsson K
    Blood; 1989 Aug; 74(2):786-92. PubMed ID: 2787679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
    Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
    Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low blood lymphocyte count is associated with an expansion of activated cytotoxic lymphocytes in patients with B-cell chronic lymphocytic leukaemia.
    Martín AP; Martín ER; García-Suárez J; Arriagada FC; del Puerto Hernandez-Fuentes M; Vilaplana JC; Alvarez-Mon Soto M
    Eur J Haematol; 1997 Aug; 59(2):89-99. PubMed ID: 9293856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation.
    Scrivener S; Kaminski ER; Demaine A; Prentice AG
    Br J Haematol; 2001 Mar; 112(4):959-64. PubMed ID: 11298591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small lymphocytic non-Hodgkin's lymphoma of suppressor/cytotoxic T-cell phenotype [CD4(-), CD8(+)].
    Dorfman DM; Longtine JA; Weinberg DS; Pinkus GS
    Hum Pathol; 1993 Nov; 24(11):1253-6. PubMed ID: 8244326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
    Cordone I; Matutes E; Catovsky D
    Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic lymphocytic leukemia with peripheral T lymphocytes expressing CD 2+, CD 3+, CD 4-, CD 8-, CD 16+, and CD 56+ and lymph-node lymphocytes expressing CD 2+, CD 3-, CD 4-, CD 8-, CD 16+, CD 38+, and CD 56+].
    Furukawa Y; Tanaka K; Hasuike T; Hirai M; Masuzawa K; Ohira H; Ota K; Yasui Y; Nakao Y; Inoue T
    Rinsho Byori; 1991 May; 39(5):557-61. PubMed ID: 1712868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).
    Frolova EA; Richards SJ; Jones RA; Rawstron A; Master PS; Teasdale J; Short M; Jack AS; Scott CS
    Leuk Lymphoma; 1995 Jan; 16(3-4):307-18. PubMed ID: 7719238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of T-lymphocyte-subsets and their consequences in B-CLL.
    Burger T; Molnár L; Schmelczer M; Tóvári E; Szabó A; Paál M; Királyfalvi L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):115-25. PubMed ID: 1695165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic myocarditis associated with T-cell subset changes and depressed natural killer activity.
    Kanda T; Ohshima S; Yuasa K; Watanabe T; Suzuki T; Murata K
    Jpn Heart J; 1990 Sep; 31(5):741-4. PubMed ID: 2125666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of CD69 on T cells as an early immune marker for human cytomegalovirus reactivation in chronic lymphocytic leukemia patients.
    Petersen CC; Nederby L; Roug AS; Skovbo A; Peterslund NA; Hokland P; Nielsen B; Hokland M
    Viral Immunol; 2011 Apr; 24(2):165-9. PubMed ID: 21449727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood lymphocyte phenotype of ZAP-70⁺ and ZAP-70⁻ patients with B-cell chronic lymphocytic leukaemia.
    Rivkina A; Holodnuka-Kholodyuk I; Murovska M; Soloveichika M; Lejniece S
    Exp Oncol; 2015 Mar; 37(1):73-6. PubMed ID: 25804237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of T helper and suppressor lymphocyte subsets in relation to the clinical stage of solid neoplasms.
    Tancini G; Barni S; Rescaldani R; Fiorelli G; Vivani S; Lissoni P
    Oncology; 1990; 47(5):381-4. PubMed ID: 2145536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year evaluation of clinical and laboratory variables of immune function in 117 hemophiliacs seropositive or seronegative for HIV-1.
    Teitel JM; Freedman JJ; Garvey MB; Kardish M
    Am J Hematol; 1989 Dec; 32(4):262-72. PubMed ID: 2573270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.
    Aguilar-Santelises M; Loftenius A; Ljungh C; Svenson SB; Andersson B; Mellstedt H; Jondal M
    Leuk Res; 1992; 16(6-7):607-13. PubMed ID: 1386130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia.
    Musolino C; Di Cesare E; Alonci A; Allegra A; Orlando A; Grosso P; Squadrito G
    Acta Haematol; 1991; 85(2):57-61. PubMed ID: 1902614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.